Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
about
A genetic model for gallbladder carcinogenesis and its dissemination.Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.Re-splicing of mature mRNA in cancer cells promotes activation of distant weak alternative splice sites.Domesticated transposable element gene products in human cancer.Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma.TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cellsPKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells.Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression
P2860
Q33683102-4A1F57DB-7D08-4F1E-876A-9BE59A8DA71FQ33805874-4807C122-6790-46D2-8D4A-39459B8909A3Q34147704-BD05EAE3-7197-4F14-A881-8F856E78A101Q36186975-5F92755A-CCA6-47B4-8CC3-CC2AA21B8053Q36228562-15EA7C30-2ED0-4F62-8B0C-4B8092D64BAEQ38164002-3461B601-9B44-4946-93A9-529A5CD962C8Q38888510-D6D5FB54-98E7-45DF-B986-407F6C2898F1Q42654576-0536E25A-051D-4806-95BD-98272CC832BEQ42677448-9A11DF13-306C-42CE-A971-833F82EB9C09Q44235056-1CBB6F36-6386-4525-B3A7-EF4BFBCD2B66Q48042328-CF709348-7360-43C9-9D11-5B03BB96CA04Q51445413-0DF30E0D-746A-4060-B53A-CD0A59CDF181Q53424906-8E237396-5E1A-460A-888F-FA8F47BC84D9Q58786432-9EA5B05C-5BE5-440D-8592-A527E6C9544A
P2860
Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Identification of PEG10 and TS ...... or gallbladder adenocarcinoma.
@en
Identification of PEG10 and TS ...... or gallbladder adenocarcinoma.
@nl
type
label
Identification of PEG10 and TS ...... or gallbladder adenocarcinoma.
@en
Identification of PEG10 and TS ...... or gallbladder adenocarcinoma.
@nl
prefLabel
Identification of PEG10 and TS ...... or gallbladder adenocarcinoma.
@en
Identification of PEG10 and TS ...... or gallbladder adenocarcinoma.
@nl
P2093
P2860
P1476
Identification of PEG10 and TS ...... or gallbladder adenocarcinoma.
@en
P2093
Dong-cai Liu
Song Jiang
Zhu-lin Yang
P2860
P2888
P304
P356
10.1007/S12253-011-9394-7
P577
2011-04-01T00:00:00Z